These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15535339)

  • 1. Risk factors for anti tuberculous drugs induced hepatitis: a prospective survey from a chest clinic in a general hospital.
    Fauzi AR; Shah A; Rathor MY; Satwi S
    Med J Malaysia; 2004 Mar; 59(1):72-7. PubMed ID: 15535339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
    Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
    Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury.
    Zuberi BF; Zuberi FF; Bader N; Alvi H; Salahuddin J
    J Pak Med Assoc; 2014 Aug; 64(8):896-9. PubMed ID: 25252514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of anti-tuberculosis drug-induced hepatotoxicity.
    Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.
    Pande JN; Singh SP; Khilnani GC; Khilnani S; Tandon RK
    Thorax; 1996 Feb; 51(2):132-6. PubMed ID: 8711642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity.
    Fernández-Villar A; Sopeña B; Fernández-Villar J; Vázquez-Gallardo R; Ulloa F; Leiro V; Mosteiro M; Piñeiro L
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1499-505. PubMed ID: 15636498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.
    Pukenyte E; Lescure FX; Rey D; Rabaud C; Hoen B; Chavanet P; Laiskonis AP; Schmit JL; May T; Mouton Y; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):78-84. PubMed ID: 17217134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
    Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
    Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective survey of drug induced hepatotoxicity in a large hospital.
    Kshirsagar NA; Karande SC; Potkar CN
    Indian J Gastroenterol; 1992 Jan; 11(1):13-5. PubMed ID: 1551705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinic and pathogenesis of drug hepatitis].
    Mardare G
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(1):43-5. PubMed ID: 25591247
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of 93 cases of drug induced hepatitis].
    Lu MH; Yang YX; Tan DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):608-9. PubMed ID: 16137063
    [No Abstract]   [Full Text] [Related]  

  • 15. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
    Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM].
    Chen GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survey of anti-tuberculosis drug-induced severe liver injury in Japan].
    Shigeto E;
    Kekkaku; 2007 May; 82(5):467-73. PubMed ID: 17564126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
    Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
    Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatotoxicity of antitubercular drugs. Apropos of 28 cases].
    Sakhri A; Ben Kemla S; Khadraoui M; Cheikh R
    Tunis Med; 2003 Jul; 81(7):488-94. PubMed ID: 14534960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.